by jlohrconsulting | Aug 28, 2025 | Uncategorized
Hong Kong Med J. 2025 Aug 28. doi: 10.12809/hkmj2513594. Online ahead of print. NO ABSTRACT PMID:40867028 | DOI:10.12809/hkmj2513594
by jlohrconsulting | Aug 28, 2025 | Uncategorized
Neuropharmacology. 2025 Aug 25:110658. doi: 10.1016/j.neuropharm.2025.110658. Online ahead of print. ABSTRACT A neuronal, phenotypic in vitro screen at Idorsia identified IDOR-1104-0086 as a small molecule with antiseizure effects and drug-like properties. Target...
by jlohrconsulting | Aug 28, 2025 | Uncategorized
Proc Natl Acad Sci U S A. 2025 Sep 2;122(35):e2421800122. doi: 10.1073/pnas.2421800122. Epub 2025 Aug 27. ABSTRACT Precise, noninvasive drug delivery to small but important brain regions is challenging and highly desired given the brain’s inherent complexity and...
by jlohrconsulting | Aug 28, 2025 | Uncategorized
Curr Issues Mol Biol. 2025 Jul 23;47(8):581. doi: 10.3390/cimb47080581. ABSTRACT The insulin-like growth factor binding protein, acid-labile subunit (IGFALS), plays a crucial role in glucose metabolism and immune regulation, key processes in recovery from surgery....
by jlohrconsulting | Aug 28, 2025 | Uncategorized
Curr Issues Mol Biol. 2025 Jul 24;47(8):587. doi: 10.3390/cimb47080587. ABSTRACT Depression in cancer survivors is commonly treated with serotonin and norepinephrine reuptake inhibitors (SNRIs), such as venlafaxine. These drugs alleviate depressive symptoms by...
by jlohrconsulting | Aug 28, 2025 | Uncategorized
Psychiatry Clin Psychopharmacol. 2025 Aug 11;35(Suppl 1):S36-S46. doi: 10.5152/pcp.2025.24984. ABSTRACT Background: The prevalence of trauma-related disorders in Türkiye is higher than in high-income countries due to an increased likelihood of exposure to traumatic...
Recent Comments